Best Cardiovascular Surgeons for Heart Valve Replacement Surgery in Hyderabad, India

Endocarditis is an infection — most commonly bacterial — of the endocardium, the tissue lining the inside of the heart, particularly the heart valves. It can affect native valves as well as artificial (prosthetic) valves and implanted cardiac devices.

Common presentations include persistent fever, chills, night sweats, unexplained fatigue, a new or changed heart murmur, joint pain, and in some cases small skin lesions or red spots under the nails (splinter hemorrhages) or on the palms and soles. More serious complications such as sudden neurological symptoms, chest pain, or shortness of breath can indicate valve destruction or septic emboli reaching the brain, lungs, or other organs. These symptoms overlap with many other conditions, and their presence or absence does not confirm or rule out endocarditis — formal clinical and laboratory evaluation is essential.

Diagnosis is typically guided by the Duke Criteria, a validated clinical framework that combines blood culture findings, echocardiographic evidence of valve or endocardial involvement, and additional clinical and laboratory markers to classify cases as definite, possible, or rejected. Transthoracic echocardiography (TTE) is usually the first imaging step, but transoesophageal echocardiography (TOE/TEE) is often needed for clearer visualisation of valve structures, abscesses, or prosthetic valve involvement. Additional investigations — including serial blood cultures, inflammatory markers (CRP, ESR, procalcitonin), full blood count, and, where available, advanced imaging such as cardiac CT or PET-CT — are selected based on individual clinical presentation and the treating team's judgment.

Treatment approach depends on the causative organism, the severity of valve damage, whether complications such as heart failure, abscess, or embolic events have occurred, and the patient's overall clinical condition. Prolonged intravenous antibiotic therapy — typically four to six weeks — is the cornerstone of management for most patients and may be sufficient when valve damage is limited and there are no major complications. When structural damage is significant, when infection cannot be controlled medically, or when there is a high ongoing embolic risk, heart valve repair or replacement surgery becomes necessary, and the timing of any intervention is a decision made by a specialist team after individual assessment.

Many patients with endocarditis are managed successfully with intravenous antibiotic therapy alone, guided by blood culture sensitivities and delivered under close inpatient or, in carefully selected stable cases, outpatient parenteral antibiotic therapy (OPAT) programmes. Regular clinical monitoring, repeat echocardiography, and laboratory follow-up are integral to non-surgical management to detect early signs of deterioration. However, it is important to understand that for patients who develop significant valve dysfunction, uncontrolled infection, or embolic complications, medical therapy alone is unlikely to be sufficient and surgical evaluation becomes necessary.

Heart Valve Replacement Surgery may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.

Endocarditis is typically managed by an infectious disease specialist working closely with a cardiologist experienced in valvular heart disease; when surgical intervention is required, a cardiothoracic surgeon becomes a core member of the care team. Many leading centres convene a dedicated 'endocarditis team' — a multidisciplinary group that may also include a cardiac anaesthesiologist, a neurologist, and a microbiologist — to coordinate decisions, particularly in complex or high-risk cases.

When seeking care for endocarditis, it is worth asking about a centre's access to a dedicated multidisciplinary endocarditis team, its volume of surgically managed endocarditis cases, the availability of transoesophageal echocardiography and advanced cardiac imaging, and the arrangements for long-term follow-up after discharge. For patients requiring valve surgery, understanding the surgeon's specific experience with infective endocarditis — which carries distinct surgical challenges compared with non-infective valve disease — is particularly important.

Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.

Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.